Graham Walmsley
Director/Board Member at AKERO THERAPEUTICS, INC.
Net worth: 41 040 $ as of 2024-04-29
Profile
Dr. Graham G.
Walmsley is an Independent Director at Olema Pharmaceuticals, Inc., a Managing Partner at Logos Capital Fund LLP, a General Partner at Logos Global Management LP and an Independent Non-Executive Director at Akero Therapeutics, Inc. He is on the Board of Directors at Olema Pharmaceuticals, Inc., ALX Oncology, Inc. and Akero Therapeutics, Inc. Dr. Walmsley was previously employed as an Independent Director by Lifesci Acquisition II Corp., an Independent Director by ALX Oncology Holdings, Inc., a Head-Business Development by Pipeline Therapeutics, Inc., a Head-Business Development by Jecure Therapeutics, Inc., and a Principal by Versant Venture Management LLC.
He also served on the board at Science 37 Holdings, Inc. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Stanford University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AKERO THERAPEUTICS, INC.
0.00% | 2024-04-01 | 2,168 ( 0.00% ) | 41 040 $ | 2024-04-29 |
| 2024-04-22 | 0 ( -.--% ) | - $ | 2024-04-29 |
Graham Walmsley active positions
| Companies | Position | Start |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 2018-05-31 |
| OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 2020-02-29 |
Logos Capital Fund LLP
 Logos Capital Fund LLP Investment Trusts/Mutual FundsMiscellaneous Logos Capital Fund LLP functions as pooled investment fund. The company is headquartered in Rehoboth, DE. | Founder | 2019-07-31 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Director/Board Member | 2020-01-31 |
Logos Global Management LP
 Logos Global Management LP Investment ManagersFinance Logos Global Management LP (Logos) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Arsani William and Graham Walmsley in 2019. They are owned and controlled by Logos Global Management GP LLC. Logos provides discretionary investment management services to privately offered pooled investment vehicles. | Founder | 2019-02-28 |
Former positions of Graham Walmsley
| Companies | Position | End |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Director/Board Member | 2021-07-31 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Private Equity Investor | 2019-07-31 |
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2019-02-28 |
| CONTINEUM THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-11-30 |
| ░░░░░░░ ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Graham Walmsley
| University of California, Berkeley | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| AKERO THERAPEUTICS, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| SCIENCE 37 HOLDINGS, INC. | Commercial Services |
| Private companies | 6 |
|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Logos Capital Fund LLP
Logos Capital Fund LLP Investment Trusts/Mutual FundsMiscellaneous Logos Capital Fund LLP functions as pooled investment fund. The company is headquartered in Rehoboth, DE. | Miscellaneous |
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Commercial Services |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Health Technology |
Lifesci Acquisition II Corp.
 Lifesci Acquisition II Corp. Financial ConglomeratesFinance LifeSci Acquisition II Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2019 and is headquartered in New York, NY. | Finance |
Logos Global Management LP
Logos Global Management LP Investment ManagersFinance Logos Global Management LP (Logos) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Arsani William and Graham Walmsley in 2019. They are owned and controlled by Logos Global Management GP LLC. Logos provides discretionary investment management services to privately offered pooled investment vehicles. | Finance |
- Stock Market
- Insiders
- Graham Walmsley
